Part of a comprehensive analysis of the Human Biomedical Research Act 2015
All Parts in This Series
Analysis of Part 7: Codes of Practice and Ethics under the Human Biomedical Research Act 2015
The Human Biomedical Research Act 2015 (the “Act”) establishes a comprehensive regulatory framework governing human biomedical research and tissue banking activities in Singapore. Part 7 of the Act, titled “Codes of Practice and Ethics,” plays a pivotal role in guiding the conduct of research and safeguarding the rights and welfare of research participants. This analysis examines the key provisions of Part 7, their purposes, and the legal implications for stakeholders involved in human biomedical research.
Section 40(1): Authority of the Director-General to Issue and Approve Codes
"The Director‑General may, from time to time — (a) issue one or more codes of practice for the purpose of providing guidance with respect to the requirements of this Act relating to the taking of consent, safety and research practices and for standards; (b) issue one or more codes of practice for the protection of the identity of individuals in relation to individually‑identifiable human biological material and health information; (c) issue one or more codes of ethics for the ethical conduct of human biomedical research or tissue banking activity; (d) approve as a code of practice or a code of ethics any document prepared by another person or body of persons other than the Director‑General, if the Director‑General considers the document as suitable for this purpose; and (e) amend or revoke the whole or part of any code of practice or code of ethics issued under paragraph (a), (b) or (c) or approved under paragraph (d)." — Section 40(1), Human Biomedical Research Act 2015
Verify Section 40 in source document →
This provision grants the Director-General broad authority to issue, approve, amend, or revoke codes of practice and ethics. The purpose of this authority is multifold:
- Guidance on Consent, Safety, and Research Practices: Subsection (a) empowers the Director-General to issue codes that clarify the procedural and substantive requirements for obtaining informed consent, ensuring participant safety, and maintaining high standards in research conduct. This is essential to uphold ethical and legal standards in biomedical research.
- Protection of Identity: Subsection (b) addresses the critical need to protect the privacy and confidentiality of individuals whose biological materials and health information are used in research. This reflects the Act’s commitment to safeguarding personal data and preventing misuse.
- Ethical Conduct: Subsection (c) allows for the issuance of codes of ethics, which set out the moral principles and professional standards expected of researchers and tissue bankers. This ensures that research activities align with societal values and ethical norms.
- Flexibility and Inclusiveness: Subsection (d) permits the Director-General to adopt external documents as codes, promoting harmonisation with international standards or expert guidelines. This flexibility facilitates the incorporation of best practices from recognised bodies.
- Dynamic Regulation: Subsection (e) enables the Director-General to update or revoke codes to respond to evolving scientific, ethical, or legal developments, ensuring that the regulatory framework remains current and effective.
Overall, Section 40(1) exists to provide a structured yet adaptable mechanism for the continuous development and dissemination of authoritative guidance and ethical standards in human biomedical research.
Section 40(2): Publication of Codes and Amendments
"The Director‑General must publish any code of practice or code of ethics issued or approved under subsection (1), including any amendment or revocation of the code, in such manner as the Director‑General thinks fit." — Section 40(2), Human Biomedical Research Act 2015
Verify Section 40 in source document →
This subsection mandates transparency and accessibility by requiring the Director-General to publish all codes and any subsequent amendments or revocations. The rationale behind this provision is to ensure that all stakeholders—researchers, institutions, ethics committees, and the public—are informed of the current standards and ethical requirements. Publication facilitates compliance, promotes accountability, and fosters trust in the regulatory system.
Section 41(1): Non-Criminal Liability for Failure to Observe Codes
"A person is not liable to any criminal proceedings by reason only that the person has failed to observe any code of practice or code of ethics issued or approved under section 40." — Section 41(1), Human Biomedical Research Act 2015
Verify Section 41 in source document →
This provision clarifies that non-compliance with codes of practice or ethics, in itself, does not constitute a criminal offence. The purpose of this safeguard is to distinguish between mandatory legal requirements and advisory or guiding documents. Codes serve as standards and best practices rather than enforceable laws carrying criminal sanctions. This distinction encourages voluntary adherence to ethical norms without the deterrent effect of criminal liability, while still allowing for other legal consequences or disciplinary actions where appropriate.
Absence of Explicit Definitions in Part 7
Notably, Part 7 does not contain explicit definitions of terms used within the provisions on codes of practice and ethics. This absence suggests that the Act relies on definitions provided elsewhere or on commonly understood meanings within the biomedical research context. The lack of definitions may also reflect the flexible and evolving nature of codes, which can be adapted to emerging scientific and ethical considerations without being constrained by rigid statutory definitions.
Implications for Human Biomedical Research and Tissue Banking
The provisions in Part 7 collectively establish a framework that balances regulatory oversight with flexibility and ethical guidance. By empowering the Director-General to issue and update codes, the Act ensures that research practices remain aligned with current scientific knowledge and societal expectations. The publication requirement promotes transparency, while the non-criminal liability clause encourages compliance without fear of undue penalisation.
For researchers and institutions, adherence to these codes is essential for maintaining ethical standards, protecting participant rights, and fostering public confidence in biomedical research. Although failure to observe the codes does not attract criminal penalties, it may have other consequences such as administrative sanctions, loss of funding, or reputational damage.
Conclusion
Part 7 of the Human Biomedical Research Act 2015 plays a crucial role in shaping the ethical and operational landscape of human biomedical research in Singapore. The Director-General’s authority to issue, approve, and amend codes ensures that guidance remains relevant and authoritative. The publication requirement guarantees accessibility, and the non-criminal liability provision delineates the advisory nature of these codes. Together, these provisions underpin a robust yet adaptable regulatory environment that promotes ethical research and protects the interests of individuals involved in biomedical studies.
Sections Covered in This Analysis
- Section 40(1) – Director-General’s authority to issue and approve codes of practice and ethics
- Section 40(2) – Publication of codes and amendments
- Section 41(1) – Non-criminal liability for failure to observe codes
Source Documents
For the authoritative text, consult SSO.